 |
|
|
|
|
|
|
 |
|
 |
|
|||
 |
|
|||||
 |
 |
 |
 |
|
||
 |
|
|||||
|
||||||
 |
|
|||||
 
|
 |
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
|
|
 
|
|
Press Releases ---------------------------------------------------------------- FOR IMMEDIATE RELEASE
IRIS TO RELEASE FIRST QUARTER FINANCIAL RESULTS AND HOST CONFERENCE CALL ON WEDNESDAY, MAY 9 CHATSWORTH, Calif., May 1, 2007 — IRIS International, Inc. (NASDAQ GM: IRIS) will hold a conference call with members of the investment community on Wednesday, May 9, at 4:30 p.m. Eastern time. César García, President and Chief Executive Officer, and Veronica Tarrant, Interim Chief Financial Officer, will be reviewing the Company's financial results for the first quarter ended March 31, 2007, which will be announced at the close of market that day. To participate, dial 1-866-550-6338 approximately 10 minutes before the conference call is scheduled to begin. Hold for the operator and reference the IRIS International conference call. International callers should dial 347-284-6930. The conference call may also be accessed by means of a live audio Webcast on the Company's Web site at www.proiris.com, or at the Webcast service provider's site, http://www.vcall.com/IC/CEPage.asp?ID=114905. The conference audio cast will also be archived for replay on both Web sites for 30 days from the date of the broadcast. For anyone who is unable to participate in the conference, access to a recording will be available for seven days following the call. Dial 1-888-203-1112 to access playback. For international callers, dial 719-457-0820. The pass code I.D. is 6740211. THE COMPANY IRIS International, Inc. (www.proiris.com), based in Chatsworth, Calif., is a leading developer, manufacturer, and marketer of medical devices, diagnostic systems and consumables. The Iris Diagnostics Division (www.irisdiagnostics.com) is a leader in automated urinalysis technology with systems in major medical institutions throughout the world. The Company's Sample Processing business unit (formerly the StatSpin® subsidiary) (www.statspin.com), based in Westwood, Mass., manufactures innovative centrifuges and blood analysis products. The Iris Molecular Diagnostics (IMD) Subsidiary, based in San Diego, Calif., develops innovative ultra-sensitive diagnostics and sample processing products with applications in the urinalysis, oncology and infectious disease markets. Advanced Digital Imaging Research, LLC (ADIR), based near Houston, Tex., is the Company's imaging research and development subsidiary. |
